Welcome to our dedicated page for FIGS SEC filings (Ticker: FIGS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
FIGS, Inc. filings document the company’s healthcare apparel business, operating results and public-company governance. Form 8-K reports furnish earnings releases and Regulation FD presentations covering net revenues, scrubwear and non-scrubwear categories, U.S. and international sales, active customer measures, average order value, gross margin, operating expenses and outlook disclosures.
The company’s proxy materials address board matters, executive compensation, equity awards and annual meeting governance. Other current reports disclose material agreements, including office lease arrangements related to corporate facilities. Together, FIGS’ regulatory filings describe the business economics, capital and compensation structures, governance practices and material events of a direct-to-consumer healthcare apparel issuer.
FIGS, Inc. reported strong first quarter 2026 results, with net revenues of $159.9 million, up 28.0% year over year, driven by more orders from both new and existing customers and higher average order value.
Scrubwear net revenues were $126.6 million, while non-scrubwear reached $33.3 million. U.S. net revenues grew 24.1% to $131.6 million, and international net revenues rose 49.9% to $28.3 million.
The company delivered net income of $6.3 million, or $0.03 diluted earnings per share, versus a small loss a year earlier. Net income margin was 3.9%, and adjusted EBITDA was $13.9 million with an 8.7% adjusted EBITDA margin.
Active customers grew 12.2% to 3.0 million, net revenues per active customer rose to $220, and average order value increased to $124. Reflecting this momentum, FIGS raised its full year 2026 outlook, now targeting net revenues growth of 14% to 16% and adjusted EBITDA margin of 13.0% to 13.2%.
FIGS, Inc. Chief Financial Officer Sarah Oughtred reported an open-market sale of 23,597 shares of Class A Common Stock at a weighted average price of $14.3339 per share. The footnotes state these shares were sold solely to cover taxes and fees due on the vesting and settlement of restricted stock units, under a pre-arranged Rule 10b5-1 instruction letter.
After the transaction, Oughtred directly owns 1,129,791 shares, including 953,028 RSUs, each representing a contingent right to receive one share of Class A Common Stock. The sales occurred in multiple trades at prices ranging from $14.160 to $14.344 per share.
FIGS, Inc. Executive Chairman Heather L. Hasson reported an open-market sale of 32,385 shares of Class A Common Stock at a weighted average price of $14.3339 per share. According to the filing, all shares were sold solely to cover taxes and fees owed on vesting RSUs under a pre-arranged Rule 10b5-1 instruction letter.
Following the sale, Hasson directly holds 1,433,807 Class A shares. She also has indirect holdings of 141 Class A shares through Hollywood Capital Partners LLC and 8,338 Class A shares through the Heather Hasson Revocable Trust, along with 984,368 RSUs, 2,814,480 Class B shares convertible into Class A, and 10,995,729 Class A shares underlying vested options.
Sarah Oughtred / FIGS, Inc. submitted a Form 144 notice reporting a proposed sale of 41,051 shares of Class A Common Stock, consisting of shares acquired upon vesting of Restricted Stock Units under the 2021 Equity Incentive Award Plan on 05/01/2026. The filing also lists prior sales of 10,872 shares on 04/02/2026 and 22,690 shares on 02/05/2026.
Heather Hasson reported proposed sales of Class A Common Stock in a Form 144 notice. The filing lists 59,242 shares acquired upon vesting of Restricted Stock Units under the 2021 Equity Incentive Award Plan on 05/01/2026. It also records previously sold shares in the past three months: 556,327 shares on 03/03/2026 and 22,874 shares on 02/05/2026. The 144 identifies FIGS, Inc. as the issuer and notes the vesting was for services rendered.
FIGS, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on June 3, 2026. Investors will elect three Class II directors, ratify Ernst & Young LLP as auditor for 2026, and cast an advisory Say-on-Pay vote on executive compensation.
Holders of Class A and Class B common stock vote together as of April 8, 2026, when 158,761,109 Class A shares and 8,283,641 Class B shares were outstanding. Class A carries one vote per share and Class B carries twenty votes, leaving Class B with 51.1% of voting power. A voting agreement between co-founders supports FIGS’ status as a NYSE “controlled company.”
The proxy also details board structure, committee responsibilities, and governance policies, along with human capital, community and sustainability initiatives. FIGS reports using WRAP-certified apparel suppliers and notes it donated $700,000 to healthcare-related causes in 2025 and employed 388 team members as of year-end 2025.
FIGS, Inc. Chief Financial Officer Sarah Oughtred reported an open-market sale of 10,872 shares of Class A Common Stock at $14.4389 per share. According to the disclosure, these shares were sold solely to cover required taxes and fees triggered by the vesting and settlement of restricted stock units (RSUs).
The sales were executed under a pre-arranged Rule 10b5-1 instruction letter delivered on August 13, 2024, and were not made for any other purpose. After the transaction, Oughtred holds 1,153,388 shares directly, including 994,079 RSUs, each representing a contingent right to receive one share of Class A Common Stock.
FIGS, Inc. Chief Executive Officer Catherine Eva Spear reported an open-market sale of 62,335 shares of Class A Common Stock at $14.4389 per share. Footnotes state these shares were sold solely to cover taxes and fees due upon the vesting and settlement of restricted stock units, under a pre-arranged Rule 10b5-1 instruction letter.
After the sale, she holds 1,794,964 Class A shares directly, plus 797,073 Class A shares held by the Catherine Spear Revocable Trust and 141 Class A shares held by Hollywood Capital Partners LLC. Footnotes also note 1,097,946 RSUs, 5,469,161 Class B shares and 19,633,407 Class A shares underlying vested options, indicating a large remaining equity position.
FIGS submitted a Form 144 reporting proposed transactions in Class A Common Stock. The filing lists 20,067 shares acquired upon vesting of Restricted Stock Units on 04/01/2026, and a prior sale of 22,690 shares on 02/05/2026. The filing also shows a numeric line with 158,093,481 and date 04/02/2026 in the securities block.